Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8+ T cells and protect from type 1 diabetes

European Journal of Immunology

Volumn 43, Issue 1, 2013, Pages 209-218

  Simon, Thomas ^a,b,c   Pogu, Sylvie ^a,b   Tardif, Virginie ^a,c,d   Rigaud, Kevin ^a,b,c,d   Rémy, Séverine ^a,c,d   Piaggio, Eliane ^e   Bach, Jean Marie ^a,b   Anegon, Ignacio ^a,c,d   Blancou, Philippe ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b CEMAGREF   (France)

^c Centre National de la Recherche Scientifique   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

1 integrin; Autoreactive CD8+ T cells; Carbon monoxide; Dendritic cells; Diabetes

Indexed keywords

BETA1 INTEGRIN; CARBON MONOXIDE; HA 512520; INTERLEUKIN 10; NP 147155; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD29; AUTOANTIGENS; CARBON MONOXIDE; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; IMMUNE TOLERANCE; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; PANCREAS; PEPTIDE FRAGMENTS;

EID: 84872488294     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242684     Document Type: Article

References (54)

1. Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K. et al., A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005. 54: 1763-1769.
2. Luo, X., Herold, K. C. and Miller, S. D., Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity 2010. 32: 488-499.
3. Manicassamy, S. and Pulendran, B., Dendritic cell control of tolerogenic responses. Immunol. Rev. 241: 206-227.
4. Denucci, C. C., Mitchell, J. S. and Shimizu, Y., Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there. Crit. Rev. Immunol. 2009. 29: 87-109.
5. Owens, E. O., Endogenous carbon monoxide production in disease. Clin. Biochem. 2010. 43: 1183-1188.
6. Chora, A. A., Fontoura, P., Cunha, A., Pais, T. F., Cardoso, S., Ho, P. P., Lee, L. Y. et al., Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 2007. 117: 438-447.
7. Li, M., Peterson, S., Husney, D., Inaba, M., Guo, K., Kappas, A., Ikehara, S. et al., Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 2007. 6: 567-571.
8. Hu, C. M., Lin, H. H., Chiang, M. T., Chang, P. F. and Chau, L. Y., Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes 2007. 56: 1240-1247.
9. Xia, Z. W., Zhong, W. W., Xu, L. Q., Sun, J. L., Shen, Q. X., Wang, J. G., Shao, J. et al., Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J. Immunol. 2006. 177: 5936-5945.
10. Chauveau, C., Bouchet, D., Roussel, J., Mathieu, P., Braudeau, C., Renaudin, K., Tesson, L. et al., Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am. J. Transplant. 2002. 2: 581-592.
11. Braudeau, C., Bouchet, D., Tesson, L., Iyer, S., Remy, S., Buelow, R., Anegon, I. et al., Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther. 2004. 11: 701-710.
12. Soares, M. P., Lin, Y., Anrather, J., Csizmadia, E., Takigami, K., Sato, K., Grey, S. T. et al., Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 1998. 4: 1073-1077.
13. Bach, F., Hancock, W. and Ferran, C., Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol. Today 1997. 18: 483-486.
14. Hancock, W. W., Buelow, R., Sayegh, M. H. and Turka, L. A., Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 1998. 4: 1392-1396.
15. Blancou, P. and Anegon, I., Editorial: heme oxygenase-1 and dendritic cells: what else? J. Leukoc. Biol. 2010. 87: 185-187.
16. Chauveau, C., Remy, S., Royer, P., Hill, M., Tanguy-Royer, S., Hubert, F. X., Tesson, L. et al., Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression. Blood 2005. 106: 1694-1702.
17. Remy, S., Blancou, P., Tesson, L., Tardif, V., Brion, R., Royer, P. J., Motterlini, R. et al., Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J. Immunol. 2009. 182: 1877-1884.
18. Dong, D. L., Chen, C., Huang, W., Chen, Y., Zhang, X. L., Li, Z., Li, Y. et al., Tricarbonyldichlororuthenium (II) dimer (CORM2) activates non-selective cation current in human endothelial cells independently of carbon monoxide releasing. Eur. J. Pharmacol. 2008. 590: 99-104.
19. Lo, D., Freedman, J., Hesse, S., Palmiter, R. D., Brinster, R. L. and Sherman, L. A., Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur. J. Immunol. 1992. 22: 1013-1022.
20. Bercovici, N., Heurtier, A., Vizler, C., Pardigon, N., Cambouris, C., Desreumaux, P. and Liblau, R., Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage. J. Immunol. 2000. 165: 202-210.
21. Hanninen, A., Nurmela, R., Maksimow, M., Heino, J., Jalkanen, S. and Kurts, C., Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am. J. Pathol. 2007. 170: 240-250.
22. Doucey, M. A., Legler, D. F., Faroudi, M., Boucheron, N., Baumgaertner, P., Naeher, D., Cebecauer, M. et al., The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J. Biol. Chem. 2003. 278: 26983-26991.
23. Listopad, J., Asadullah, K., Sievers, C., Ritter, T., Meisel, C., Sabat, R. and Docke, W. D., Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp. Dermatol. 2007. 16: 661-670.
24. Mashreghi, M. F., Klemz, R., Knosalla, I. S., Gerstmayer, B., Janssen, U., Buelow, R., Jozkowicz, A. et al., Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3. J. Immunol. 2008. 180: 7919-7930.
25. Nembrini, C., Abel, B., Kopf, M. and Marsland, B. J., Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells. J. Immunol. 2006. 176: 7180-7188.
26. Curtsinger, J. M., Lins, D. C. and Mescher, M. F., Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 2003. 197: 1141-1151.
27. Clarke, H. M., Shrivastava, S., Motterlini, R., Sawle, P., Chen, D. and Dorling, A., Donor HO-1 expression inhibits intimal hyperplasia in unmanipulated graft recipients: a potential role for CD8+ T-cell modulation by carbon monoxide. Transplantation 2009. 88: 653-661.
28. Savinov, A. Y., Wong, F. S., Stonebraker, A. C. and Chervonsky, A. V., Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J. Exp. Med. 2003. 197: 643-656.
29. Savinov, A. Y., Rozanov, D. V., Golubkov, V. S., Wong, F. S. and Strongin, A. Y., Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas. J. Biol. Chem. 2005. 280: 27755-27758.
30. Fousteri, G., Dave, A., Juntti, T. and von Herrath, M., CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes. J. Autoimmun. 2009. 32: 70-77.
31. Forster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E. and Lipp, M., CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999. 99: 23-33.
32. Carvalho-Pinto, C., Garcia, M. I., Gomez, L., Ballesteros, A., Zaballos, A., Flores, J. M., Mellado, M. et al., Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur. J. Immunol. 2004. 34: 548-557.
33. Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Hollander, G. A. and Piali, L., Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 2002. 8: 1414-1420.
34. Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnalek, P. et al., Natalizumab for active Crohn's disease. N. Engl. J. Med. 2003. 348: 24-32.
35. Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P., Libonati, M. A., Willmer-Hulme, A. J. et al., A controlled trial of Natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2003. 348: 15-23.
36. Soares, M. P., Seldon, M. P., Gregoire, I. P., Vassilevskaia, T., Berberat, P. O., Yu, J., Tsui, T. Y. et al., Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J. Immunol. 2004. 172: 3553-3563.
37. Seldon, M. P., Silva, G., Pejanovic, N., Larsen, R., Gregoire, I. P., Filipe, J., Anrather, J. et al., Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. J. Immunol. 2007. 179: 7840-7851.
38. Bergstraesser, C., Hoeger, S., Song, H., Ermantraut, L., Hottenrot, M., Czymai, T., Schmidt, M. et al., Inhibition of VCAM-1 expression in endothelial cells by CORM-3: the role of the ubiquitin-proteasome system, p38, and mitochondrial respiration. Free Radic. Biol. Med. 2012. 52: 794-802.
39. Kirino, M., Kirino, Y., Takeno, M., Nagashima, Y., Takahashi, K., Kobayashi, M., Murakami, S. et al., Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease. J. Allergy Clin. Immunol. 2008. 122: 290-297, 297 e291-e298.
40. Morelli, A. E. and Thomson, A. W., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007. 7: 610-621.
41. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
42. Creusot, R. J., Yaghoubi, S. S., Chang, P., Chia, J., Contag, C. H., Gambhir, S. S. and Fathman, C. G., Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 2009. 113: 6638-6647.
43. Mori, F., Bianchi, L., Pucci, N., Azzari, C., De Martino, M. and Novembre, E., CD4+CD25+Foxp3+ T regulatory cells are not involved in oral desensitization. Int. J. Immunopathol. Pharmacol. 2010. 23: 359-361.
44. Falb, D., Briner, T. J., Sunshine, G. H., Bourque, C. R., Luqman, M., Gefter, M. L. and Kamradt, T., Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy. Eur. J. Immunol. 1996. 26: 130-135.
45. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K., Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994. 1: 327-339.
46. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R. et al., Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 1996. 379: 343-346.
47. Raz, I., Elias, D., Avron, A., Tamir, M., Metzger, M. and Cohen, I. R., Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001. 358: 1749-1753.
48. Petersen, J. S., Bregenholt, S., Apostolopolous, V., Homann, D., Wolfe, T., Hughes, A., De Jongh, K. et al., Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Clin. Exp. Immunol. 2003. 134: 38-45.
49. Goubier, A., Dubois, B., Gheit, H., Joubert, G., Villard-Truc, F., Asselin-Paturel, C., Trinchieri, G. et al., Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008. 29: 464-475.
50. Burkhart, C., Liu, G. Y., Anderton, S. M., Metzler, B. and Wraith, D. C., Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int. Immunol. 1999. 11: 1625-1634.
51. Apostolou, I. and Von Boehmer, H., The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations. J. Autoimmun. 2004. 22: 111-114.
52. Piaggio, E., Mars, L. T., Cassan, C., Cabarrocas, J., Hofstatter, M., Desbois, S., Bergereau, E. et al., Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance. Proc. Natl. Acad. Sci. USA 2007. 104: 9393-9398.
53. Bedoui, S., Whitney, P. G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., Allan, R. S. et al., Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 2009. 10: 488-495.
54. Morgan, D. J., Liblau, R., Scott, B., Fleck, S., McDevitt, H. O., Sarvetnick, N., Lo, D. et al., CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 1996. 157: 978-983.